Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV [4] (multiple letters)

Archives of Internal Medicine

Volumn 158, Issue 13, 1998, Pages 1470-1471

  Frothingham, R ^a   Pinkerton, S D ^a   Holtgrave, D R ^a   Jill Pinkerton, H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; ZIDOVUDINE;

CHEMOPROPHYLAXIS; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DRUG COST; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; LETTER; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL;

ANTI-HIV AGENTS; COST-BENEFIT ANALYSIS; HIV INFECTIONS; HUMANS; INDINAVIR; LAMIVUDINE; OCCUPATIONAL EXPOSURE; UNITED STATES; ZIDOVUDINE;

EID: 0032527690     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.13.1470     Document Type: Letter

References (0)